News | August 02, 2025
Sun Pharmaceutical Q1 FY26 consolidated PAT falls by 20% to Rs. 2,278 Cr
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
3SBio will receive a payment of $1.25 billion. Pfizer will also make a $100 million equity investment in 3SBio
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Subscribe To Our Newsletter & Stay Updated
